Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 271 of 5804
-
Experimental CAR-T therapy takes on tough leukemia
Disease control Recruiting nowA Clinical Study to Investigate the Safety and Efficacy of CT0890B in Patients with Relapsed/Refractory Acute Myeloid Leukemia.
Phase: PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New combo targets genetic weakness in tough pancreatic cancer
Disease control Recruiting nowThis is a Phase 2 trial evaluating the combination of cemiplimab with the standard of care chemotherapy agent gemcitabine for the treatment of patients with metastatic pancreatic ductal adenocarcinoma with SWItch/Sucrose Non-Fermentable (SWI/SNF) alterations who have already been…
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Double defense against RSV: could Mom's vaccine plus Baby's shot be the key?
Prevention Recruiting nowRSV (which stands for Respiratory Syncytial Virus) is an infection that causes cold-like symptoms and is most common during winter months. Most people with RSV infection get better by themselves but babies and younger children can become very poorly. About 1 in 15 infants with co…
Phase: PHASE3 • Sponsor: Centre Hospitalier Annecy Genevois • Aim: Prevention
Last updated Jun 27, 2026 12:38 UTC
-
Can a blood test guide better cancer treatment after surgery?
Disease control Not yet recruitingThis study was a multicenter, randomized, phase 3 trial to determine whether adjuvant chemotherapy including tisleliizumab improves recurrence-free survival compared to follow-up alone without chemotherapy in patients with curatively resected esophageal squamous cell carcinoma.
Phase: PHASE3 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for heart patients with brain bleed history: catheter ablation vs. standard care
Disease control Recruiting nowSAFER-AF is an investigator-initiated, multicenter, open-label, parallel-group trial comparing catheter ablation versus usual care in patients with atrial fibrillation and intracerebral hemorrhage.
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Tiny radiation seeds take aim at tough pancreatic cancer
Disease control Recruiting nowA unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a blood vessel drug beat aspirin at preventing heart attacks in diabetes?
Prevention Recruiting nowPatients with type 2 diabetes and cardiovascular risk factors are at increased risk of cardiovascular events. Therefore, a multi-center prospective randomized study will be conducted to compare the efficacy and safety of cilostazol and aspirin for the prevention of major adverse …
Phase: PHASE4 • Sponsor: Seoul National University Bundang Hospital • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Second chance: new stroke treatment could save more brain tissue
Disease control Recruiting nowIschemic cerebrovascular disease is a common neurological disorder with high incidence, mortality, and disability. Early reperfusion to salvage the ischemic penumbra is the cornerstone of acute ischemic stroke (AIS) treatment. Current reperfusion strategies include intravenous th…
Phase: PHASE2 • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Simple dental exam before heart surgery may prevent deadly infections
Prevention Recruiting nowThis randomized, multicenter, open-label trial evaluates whether preoperative dental screening improves outcomes in patients undergoing surgical or transcatheter cardiac valve intervention. Participants are randomized 1:1 to preoperative dental screening or no screening. The prim…
Phase: NA • Sponsor: Region Skane • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
AI could spot breast cancer on routine chest CTs, no extra test needed
Diagnosis Recruiting nowThe goal of this observational study is to evaluate the feasibility and effectiveness of using non-contrast chest computed tomography scans for opportunistic breast cancer screening, and to further compare its diagnostic performance with conventional imaging modalities, including…
Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail shows promise in shrinking kidney tumors before surgery
Disease control Recruiting nowThe IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with Tyrosine Kinase Inhibitors (TKI) have become the standard first-line option for advanced ccRCC. Currently, IO/TKI regimens are serving as neoadjuvant treatment in arising clinical trials for ccRCC. Although…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Promising cocktail of drugs targets rare blood cancer
Disease control Not yet recruitingThis is a single-arm, open-label, multicenter phase II study evaluating sintilimab, pegaspargase, and selinexor followed by radiotherapy as first-line treatment for patients with newly diagnosed stage I/II extranodal natural killer/T-cell lymphoma (ENKTL).
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
AI takes on lymphoma: personalized treatment strategy under trial
Disease control Not yet recruitingThis is a prospective, open-label, multicenter, randomized controlled study in participants with previously untreated large B-cell lymphoma. Participants will be stratified into different risk groups using an AI-based multimodal model. Those classified as intermediate- or high-ri…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Sound waves may shield heart attack survivors from deadly rhythm problems
Disease control Not yet recruitingThe goal of this multicenter, double-blind, randomized controlled trial is to evaluate the efficacy and safety of low-intensity focused ultrasound (LIFU) stellate ganglion modulation for preventing ventricular arrhythmias after ST-segment elevation myocardial infarction (STEMI) i…
Phase: NA • Sponsor: Renmin Hospital of Wuhan University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug cocktail aims to stop head and neck cancer return
Disease control Not yet recruitingA multicenter, randomized, controlled, open-label, Phase II/III clinical trial designed to evaluate the efficacy and safety of postoperative radiotherapy combined with Nimotuzumab,with or without Bemcentinib, in postoperative head and neck squamouscell cancer patients with interm…
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New weekly shot could help sleep apnea and weight loss
Disease control Recruiting nowThis study is being done to look at the efficacy and safety of NNC0487-0111 in participants with overweight or obesity, and obstructive sleep apnoea treated with positive airway pressure. There are 2 study treatments in this study taken as injections under the skin once a week. P…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Shock therapy for BPH: new electrical ablation may spare sex life
Disease control Not yet recruitingThe study aims to find a better surgical treatment for men with an enlarged prostate (Benign Prostatic Hyperplasia, or BPH) that effectively relieves urinary symptoms without sacrificing sexual function. Currently, standard surgeries like TURP or HoLEP are very effective at open…
Phase: NA • Sponsor: Shanghai East Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for glioblastoma? drug combo trial targets aggressive brain tumors
Disease control Recruiting nowThe purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) better than using temozolomide alone in the maintenance setting. Specifically, this study is being done to find answers t…
Phase: PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New hope for tough prostate cancer: drug combo aims to delay progression
Disease control Recruiting nowThe purpose of this study is to find out whether talazoparib in combination with enzalutamide or talazoparib alone delays cancer progression in people with metastatic castration-resistant prostate cancer (mCRPC) who have homologous recombination repair (HRR) mutations and have pr…
Phase: PHASE2 • Sponsor: Prostate Cancer Clinical Trials Consortium • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New weekly shot could help sleep apnea without CPAP
Disease control Recruiting nowThis study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not treated with positive airway pressure lose weight and improve sleep apnoea. There are 2 study treatments in this study taken as inj…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC